Cargando…

Nicotine up-regulates SLC7A5 expression depending on TRIM29 in non-small cell lung cancer

Detalles Bibliográficos
Autores principales:	Liu, Dahua, Ren, Haolin, Wen, Guimin, Xia, Pu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2023
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491962/ https://www.ncbi.nlm.nih.gov/pubmed/37692503 http://dx.doi.org/10.1016/j.gendis.2023.04.016

Ejemplares similares

Both In Situ and Circulating SLC3A2 Could Be Used as Prognostic Markers for Human Lung Squamous Cell Carcinoma and Lung Adenocarcinoma
por: Liu, Dahua, et al.
Publicado: (2022)

Elevation of TRIM44 potentiates propagation of gastric cancer stem cells
por: Zhu, Hai, et al.
Publicado: (2021)

MiR-21-5p promotes the progression of non-small-cell lung cancer by regulating the expression of SMAD7
por: Li, Xiangpan, et al.
Publicado: (2018)

Gold nanoparticle–choline complexes can block nicotinic acetylcholine receptors
por: Chin, Chur, et al.
Publicado: (2010)

SLC6A1 G443D associated with developmental delay and epilepsy
por: Devries, Seth, et al.
Publicado: (2020)

Ongoing monkeypox virus outbreak, Portugal, 29 April to 23 May 2022
por: Perez Duque, Mariana, et al.
Publicado: (2022)

Autosomal recessive SLC30A9 variants in a proband with a cerebrorenal syndrome and no parental consanguinity
por: Kleyner, Robert, et al.
Publicado: (2022)

Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown-Vialetto-Van Laere syndrome
por: Haack, Tobias B., et al.
Publicado: (2012)

TRIM29 in Cutaneous Squamous Cell Carcinoma
por: Hsu, Che-Yuan, et al.
Publicado: (2021)

A SLC31A1-MEK-DNMT1-miR-124 feedback loop contributes to pancreatic cancer progression
por: Jin, Jing, et al.
Publicado: (2022)

Bilirubin inhibits lung carcinogenesis by up-regulating cystatin A expression in tumor-infiltrating macrophages
por: Huang, Qingtian, et al.
Publicado: (2023)

“High Tumor Burden” in Metastatic Non-Small Cell Lung Cancer: Defining the Concept
por: Higuera Gómez, Oliver, et al.
Publicado: (2021)

TRIM6 Reduces Ferroptosis and Chemosensitivity by Targeting SLC1A5 in Lung Cancer
por: Zhang, Ying, et al.
Publicado: (2023)

Prenatal hydrops fetalis associated with infantile free sialic acid storage disease due to a novel homozygous deletion in the SLC17A5 gene
por: Hasnain, Afia, et al.
Publicado: (2021)

TRIM29 as a Novel Biomarker in Pancreatic Adenocarcinoma
por: Sun, Hongli, et al.
Publicado: (2014)

A common missense variant of monocarboxylate transporter 9 (MCT9/SLC16A9) gene is associated with renal overload gout, but not with all gout susceptibility
por: Nakayama, Akiyoshi, et al.
Publicado: (2013)

Small Cell Lung Cancer Doubling Time and its Effect on Clinical Presentation: A Concise Review
por: Harris, Kassem, et al.
Publicado: (2012)

Anaplastic lymphoma kinase gene rearrangement in non-small-cell lung cancer in a Brazilian population
por: Lopes, Lisandro F, et al.
Publicado: (2012)

Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cells
por: Chan, Liujia, et al.
Publicado: (2022)

Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020
por: Nicolay, Nathalie, et al.
Publicado: (2020)

Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022
por: Fonager, Jannik, et al.
Publicado: (2022)

Impaired photosystem I oxidation induces STN7-dependent phosphorylation of the light-harvesting complex I protein Lhca4 in Arabidopsis thaliana
por: Ihnatowicz, Anna, et al.
Publicado: (2007)

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A
por: Reckamp, Karen L., et al.
Publicado: (2022)

A Novel Somatic Point Mutation of the RET Proto‐oncogene in Tumor Tissues of Small Cell Lung Cancer Patients
por: Futami, Hitoyasu, et al.
Publicado: (1995)

Small-cell transformation of ALK-rearranged non-small-cell adenocarcinoma of the lung
por: Balla, Agnes, et al.
Publicado: (2018)

Clinical significance of TRIM29 expression in patients with gastric cancer
por: Farhadi, Javad, et al.
Publicado: (2022)

Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study
por: Yang, James C.H., et al.
Publicado: (2020)

Mass spectrometry imaging of L-[ring-(13)C(6)]-labeled phenylalanine and tyrosine kinetics in non-small cell lung carcinoma
por: Cao, Jianhua, et al.
Publicado: (2021)

Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29)
por: Pastor-Anglada, Marçal, et al.
Publicado: (2022)

TLR7/8 stress response drives histiocytosis in SLC29A3 disorders
por: Shibata, Takuma, et al.
Publicado: (2023)

High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy
por: Gota, Vikram, et al.
Publicado: (2014)

First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer
por: Hu, Xingsheng, et al.
Publicado: (2020)

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
por: Reck, Martin, et al.
Publicado: (2021)

Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
por: Garon, Edward B., et al.
Publicado: (2019)

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
por: Paz-Ares, Luis, et al.
Publicado: (2023)

NRF2 participates in the suppressive tumor immune microenvironment of KRAS/KEAP1 co-mutant non-small cell lung cancer by inhibiting the STING pathway
por: Xiaodan, Sun, et al.
Publicado: (2022)

TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750
por: Yi, Qiyi, et al.
Publicado: (2023)

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227
por: Brahmer, Julie R., et al.
Publicado: (2023)

CD7 Expression in Malignant Pleural Mesothelioma
por: Hibi, Shigeyoshi, et al.
Publicado: (1992)

Baseline neutrophilia, derived neutrophil‐to‐lymphocyte ratio (dNLR), platelet‐to‐lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel
por: Russo, Alessandro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ptojcso16j7l4elhfeg33l9uji